Molecular simulations are used to provide insight into protein structure and function, and have the 10 potential to provide important context when predicting the impact of sequence variation on protein 11 function. In addition to understanding molecular mechanisms and interactions on the atomic scale, 12 translational applications of those approaches include drug screening, development of novel molecular 13 therapies, and treatment planning when selecting targeted therapies. Supporting the continued 14 development of these applications, we have developed the SNP2SIM workflow generates reproducible 15 molecular dynamics and molecular docking simulations for downstream functional variant analysis. Three 16 modules execute molecular dynamics simulations of solvated protein variant structures, analyze the 17 resulting trajectories for unique structural conformations, and bind small molecule ligands to 18 representative variant scaffolds. In addition to availability as a command line workflow, SNP2SIM
Molecular simulation is a powerful tool used by computational biologists to analyze the relationship 23 between protein structure and its functional properties. Ranging from high throughput drug screening to 24 focused characterization of protein conformational dynamics, the creative analysis has several 25 translational applications. Large libraries of drug candidates can be evaluated to produce novel targeted 26 therapeutics, and insight into specific molecular interactions between effective drugs and their protein 27 targets aids the design novel molecules [1, 2] . An advantage of the computational simulations is the 28 ability to probe how variation in the protein sequence alters those molecular interactions, and can be 29 extended to the development of therapies targeted at specific sequence variants [3] [4] [5] [6] . In addition to drug 30 discovery and design, the insight can be further extended to inform treatment planning when selecting an 31 optimal targeted therapeutic strategy [7] . 32
Due to an inherent tradeoff between resolution and computational requirements, molecular simulations 33 can be divided between approaches which only simulate a fraction of the overall molecule and those 34 which explicitly consider all atomic interactions occurring within the molecule. Coarse grained methods 35 which do not explicitly consider the internal interactions occurring within the protein backbone used to 36 address the enormous search space that must be interrogated when predicting how two molecules interact 37
[8]. For example, predicting how well a small molecule ligand will bind to a target protein depends on the 38 sum total of all the individual atomic interactions. Depending on the chemical nature of the ligand, the 39 conformational diversity can be quite large due to rotation around individual bonds and limited steric 40 constraints of a single ligand molecule. Furthermore, the protein surface represents a large area of 41 potential interactions and exponentially increases the degrees of freedom which must be explored when 42
identifying an optimally bound structure. In order to simplify the search for optimized protein:ligand 43 conformations and to simulate high throughput binding of large libraries of low molecular weight ligands, 44 coarse grained docking methods will typically only model the flexibility of the ligand and a small number 45 of interacting protein residues within a defined area of a rigid protein structure [8] . 46 47
for internal protein dynamics which may play a significant role in the interacting complex. All-atom 48 molecular dynamics (MD) simulations explicitly account for atomic interactions occurring within a 49 molecular system and provide a way to understand the overall conformational flexibility and structural 50 dynamics [9]. However, even systems consisting of a small, solvated protein contain tens to hundreds of 51 thousands of atoms and each simulation step requires a summation of all the forces acting on each. Even 52 on high performance computational infrastructures, simulation runs can easily last weeks to generate 53 usable results. The increased computing cost is offset by its unique insight and characterization of 54 functionally relevant protein dynamics. 55
Both approaches find utility in specific applications, and their individual strengths are leveraged to 56 understand the impact on protein sequence variation on small molecule binding. When a new amino acid 57 is specified by a change to the genomic sequence, the change in the residue side chain has the potential to 58 alter the functional interactions with a small molecule. If the change occurs within the defined search 59 space of a coarse grained binding simulation, the new interactions can be simulated directly. Typically, 60 the structures used for binding simulations are derived from x-ray crystallography, but simply swapping out amino acid side chains in the intersecting residues may not fully account for the structural differences 62 of the protein variant. Since the protein backbone is treated as a rigid scaffold, the resulting predicted 63 binding characteristics do not account for those subtle changes in the backbone geometry and could have 64 a large influence on the results. Furthermore, these methods have nothing to offer if the variation occurs 65 outside of the defined search space, especially those amino acids which are buried within the folded 66 protein structure. MD simulations can address this limitation by comprehensively sampling the 67 conformational landscape of a protein variant to generate characteristic scaffolds for downstream small 68 molecule docking. 69
Since a protein variant can alter the functional interaction with therapeutic molecules, predicting how 70 small molecules will bind to protein variants has a significant application in personalized medicine. Not 71 only can simulation results be used in the development of targeted therapies, it could also be informative 72 in the selection of second line of therapy once drug resistance has emerged. As the application of 73 molecular profiling and sequence analysis continues to gain a foothold in clinical decision making, a well-74 defined, user friendly simulation workflow and methodology would be an important tool for translational 75 computational biology. To that end, we present SNP2SIM (Figure 1) features. Representative PDB structures are generated for each unique cluster that is populated by at least 107 10% of the simulated trajectory at a given RMSD cluster threshold. The varScaffold module will accept 108 multiple PDB or DCD formatted trajectory files generated through parallel execution of the varMDsim 109 module. 110 the domain backbone and small molecule binding residues (Figure 2) , show the variants all maintain a 142 relatively stable conformational population. Despite the overall lack of molecular motion on a global 143 scale, the results show the variant structures behave differently relative to wildtype. This is reflected in 144 the deviation of the entire PD-L1 domain backbone, which is even more pronounced when only 145 considering the residues which interact with small molecule inhibitors (Figure 3) . 146
147
From the initial analysis of the variant trajectories, it's clear that certain variants induce more 148 conformational flexibility than others. This is highlighted in the breakdown of the trajectory clustering 149 results (Figure 3) , where clusters were defined by the RMSD of residues involved in binding small 150 molecules. The wildtype PD-L1 structure had two populated clusters, one just meeting the threshold of 151 10% of all sampled structures . Depending on the variant, the occupancy of additional clusters decreased 152 to one (86W, 94M, and 97V), increased to three (95R), or stayed the same (53P, 68L, and 115T), 153
illustrating the differential impact of sequence variation on the overall conformational flexibility. 154 determine their functional significance. This is especially true for variants which occur in proteins where 168 the effectiveness of targeted therapeutic strategies may be disrupted. For example, missense mutations 169 emerge in response to evolutionary pressures in a growing tumor which disrupt binding of targeted analysis and improve predictive models used for downstream drug development, design, and utilization. 180
The widespread use of molecular simulations to generate predictive data, and the insight it can provide to 181 understanding the functional changes of protein sequence variants, is rate-limited by computational costs 182 and scale of potential variation. Both of these barriers are being overcome through access to cheap cloud 183 computing and the development of reproducible workflows. And while a lot has been done to lower the 184 barrier for novice users to access these tools through widely available infrastructure such as the NCI cloud 185 pilots, creating an easy-to-use simulation and analysis workflow opens the doors to many researchers who 186 would otherwise not have access. As demonstrated through the case study of PD-L1, SNP2SIM can 187 address all these issues. The modular nature and implementation as independent apps on Seven Bridges 188 Cancer Genomics Cloud allow for parallelization, access to high performance computing resources, and a 189 user-friendly interface. 190 predictions compared to methods that provide a limited characterization of variant pathenogencity. Not 193 only does a simulation based approach provide detail about disruption of specific functional interactions, 194 it can evaluate the differential impact of somatic variation on targeted therapies. 195
